Quetiapine Tablet, Film Coated
Product Images NDC 67877-248

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 67877-248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine-100-100s (Quetiapine 100 100s)

Label for Quetiapine 100 mg film coated tablets, USP, manufactured by Alkem Laboratories Ltd. and distributed by Ascend Laboratories, LLC. The label indicates storage instructions at 25°C, prescription-only status, and a package size of 100 tablets. It includes warnings to keep out of reach of children and a barcode on the right.*

FDA Label Image

Quetiapine-150-100s (Quetiapine 150 100s)

Quetiapine 150 mg film-coated tablets label by Ascend Laboratories, LLC. This prescription oral tablet packaging indicates each tablet contains 150 mg of quetiapine fumarate USP. It includes storage instructions, a warning to keep out of reach of children, manufacturer and distributor details, and a barcode. The package contains 100 tablets.*

FDA Label Image

Quetiapine-200-100s (Quetiapine 200 100s)

Label for Quetiapine Tablets USP 200 mg, film-coated tablets for oral use, from Ascend Laboratories, LLC. The label indicates 100 tablets per container and includes storage instructions and a pharmacy dispensing warning. The product is manufactured by Alkem Laboratories Ltd., Mumbai, India, and distributed by Ascend Laboratories, NJ. The label displays the NDC 67877-246-01 and a barcode.*

FDA Label Image

Quetiapine-25-100s (Quetiapine 25 100s)

Packaging label for Quetiapine tablets, USP 25 mg, film-coated oral tablets. The label shows the product name, strength, and quantity of 100 tablets. It is manufactured by Alkem Laboratories Ltd., Mumbai, India, and distributed by Ascend Laboratories, LLC, Parsippany, NJ. Storage instructions and a warning to keep out of reach of children are included. The label features a barcode and additional product coding.*

FDA Label Image

Quetiapine-300-60s (Quetiapine 300 60s)

Label for Quetiapine Tablets, USP 300 mg by Ascend Laboratories, LLC. The label shows the proprietary name Quetiapine, strength 300 mg, dosage form as tablets, and a count of 60 tablets. It includes storage instructions, a warning to keep out of reach of children, manufacturer Alkem Laboratories Ltd. India, and distributor Ascend Laboratories, LLC, Parsippany, NJ. The label also displays the NDC 67877-247-60 and a barcode.*

FDA Label Image

Quetiapine-400-100s (Quetiapine 400 100s)

Label for Quetiapine Tablets, USP 400 mg, film-coated oral tablets packaged in a container of 100 tablets. The label is from Ascend Laboratories, LLC, and includes storage instructions, a warning to keep out of reach of children, and manufacturing information by Alkem Laboratories Ltd., Mumbai, India. It features a barcode and a note for pharmacists to dispense the enclosed medication guide.*

FDA Label Image

Quetiapine-50-100s (Quetiapine 50 100s)

Label for Quetiapine tablets, USP 50 mg, film-coated oral tablets. The label indicates the product is manufactured by Alkem Laboratories Ltd. in Mumbai, India, and distributed by Ascend Laboratories, LLC. It includes storage instructions, a caution to keep out of reach of children, and directions for pharmacists to dispense the enclosed medication guide. The package contains 100 tablets.*

FDA Label Image

Quetiapine-fig1 (Quetiapine Fig1)

A Kaplan-Meier curve chart showing time to recurrence of a mood event over approximately 100 weeks. The X-axis represents time in weeks, and the Y-axis shows the proportion of patients with relapse as a percentage. Two lines compare relapse between QTP + Li/Val and PLA + Li/Val groups, illustrating differences in patient relapse rates over time.*

FDA Label Image

Quetiapine-fig2 (Quetiapine Fig2)

Kaplan-Meier curves displaying the proportion of patients with relapse over time in weeks, comparing QTP + LI/VAL versus PLA + LI/VAL groups from a mood event study. The graph shows relapse percentage on the vertical axis and time in weeks on the horizontal axis, with QTP + LI/VAL represented by a dashed line and PLA + LI/VAL by a solid line.*

FDA Label Image

Structure (Quetiapine Stru)

Chemical structure diagram of the active ingredient quetiapine, showing the molecular structure with piperazine and dibenzothiazepine rings, along with its salt component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.